XML 42 R31.htm IDEA: XBRL DOCUMENT v3.25.3
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2025
Subsidiary, Sale of Stock [Line Items]  
Schedule of Fair Value of Instruments Issued in Offering

 

   Allocated Amount 
Common shares  $72,108 
Prefunded warrants   2,398,831 
Common warrants   3,819,274 
Net proceeds  $6,290,213 
Schedule of Fair value of Warrants Valuation Assumption

In determining the fair values of the Pre-Funded Warrants, Common Warrants, and Placement Agent Warrants, the Company used a Black-Scholes Option Pricing model with the following assumptions:

 

  

Pre-Funded

Warrants

  

Common

Warrants

  

Placement

Agent

Warrants 

 
Expected volatility   100%   103 % - 121%   103%
Contractual term   1 year    1 ½ – 5 ½ years    5 ½ years 
Risk-free interest rate   5.51%   4.57 % - 5.51%   4.57%
Expected dividend yield   0%   0%   0%
Insider Private Placement [Member]  
Subsidiary, Sale of Stock [Line Items]  
Schedule of Fair Value of Instruments Issued in Offering

 

   Allocated Amount 
Common Shares  $258,000 
Pre-Funded Warrants  $321,000 
Regular Warrants  $470,000 
Net Proceeds  $1,049,000 
Schedule of Fair value of Warrants Valuation Assumption

In determining the fair values of the Pre-Funded Warrants, Regular Warrants, and Placement Agent Warrants, the Company used a Black-Scholes Option Pricing model with the following assumptions:

 

  

Pre-Funded

Warrants

  

Regular

Warrants

  

Placement

Agent

Warrants

 
Expected volatility   134%   96%   99%
Contractual/ expected term   1 month    7 years    5 years 
Risk-free interest rate   5.53%   3.91%   3.89%
Expected dividend yield   0%   0%   0%